Letter: BMA Leads Over 20 Organizations in Opposing New Drug Rebate Executive Order

In this letter, Better Medicare Alliance led more than 20 Ally organizations in writing to HHS Secretary Azar opposing the new Executive Order eliminating current rebates in Medicare Part D, which threatens higher premiums and reduced access to supplemental benefits for Medicare Advantage beneficiaries.

Fact Sheet

Elimination of Current Manufacturer Rebates in Part D Will Harm Medicare Beneficiaries August 10, 2020

In July of 2020, the Trump administration issued an Executive Order reviving its Proposed "Rebate Rule" first issued in early 2019 that would eliminate the regulatory safe harbor protections for rebates negotiated between drug manufacturers…

Advocacy

Drug Pricing

Letter

BMA Letter Opposing Prescription Drug Rebate Changes July 22, 2020

Better Medicare Alliance sent this July 21st letter to HHS Secretary Alex Azar expressing serious concerns about the Administration possibly resurrecting its previous withdrawn rule eliminating prescription drug rebates under Part D. Better Medicare Alliance…

Advocacy

Drug Pricing